Equities

Aptamer Group PLC

APTA:LSE

Aptamer Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.23
  • Today's Change0.00 / 0.00%
  • Shares traded14.15m
  • 1 Year change-81.60%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2024 16:14 BST.
More ▼

Profile data is unavailable for this security.

About the company

Aptamer Group plc is a United Kingdom-based company that develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers next-generation aptamer tools that are enabling researchers and developers across the spectrum of the life sciences. Its Optimer binders have been developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Its Aptamer Diagnostics division uses the Company's technology to support the development of diagnostic platforms, such as proteomics, lateral flow devices, biosensors and immunoassays, such as enzyme-linked immunosorbent assay (ELISA). Its Optimer platform supports a diverse portfolio of partners and technologies.

  • Revenue in GBP (TTM)1.04m
  • Net income in GBP-7.01m
  • Incorporated2014
  • Employees54.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Truspine Technologies PLC0.00-560.51k994.68k1.00994.68k1.00
Deltex Medical Group plc1.78m-1.29m1.99m37.001.99m37.00
Image Scan Holdings Plc2.56m-11.06k3.76m14.003.76m14.00
Aptamer Group PLC1.04m-7.01m4.42m54.004.42m54.00
Surgical Innovations Group Plc12.54m-622.00k5.13m101.005.13m101.00
Feedback plc886.00k-3.49m5.47m24.005.47m24.00
Myhealthchecked PLC9.39m-1.04m6.90m10.006.90m10.00
Proteome Sciences plc4.04m-4.08m8.74m35.008.74m35.00
Cambridge Nutritional Sciences PLC9.77m-328.00k8.80m94.008.80m94.00
Rua Life Sciences PLC2.19m-1.44m9.00m33.009.00m33.00
Genincode PLC2.60m-5.94m9.29m36.009.29m36.00
Genedrive PLC272.00k-5.00m9.91m43.009.91m43.00
Renalytix PLC2.59m-35.24m13.70m80.0013.70m80.00
Data as of Oct 04 2024. Currency figures normalised to Aptamer Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

5.85%Per cent of shares held by top holders
HolderShares% Held
Interactive Investor Services Ltd.as of 31 Oct 202327.34m5.85%
Data from 01 Jul 2024 - 01 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.